![]() |
New White Paper - ISO 21973:2020Biotechnology — General requirements for transportation of cells for therapeutic use |
The International Organization for Standardization (ISO) recently issued crucial guidance for the transportation of cells for therapeutic use (ISO 21973). It is imperative for transportation service providers and therapy manufacturers to comply with these standards in order to ensure cell quality, safety and efficacy during the transportation process.
This white paper discusses key recommendations and changes that interested parties should review and evaluate when planning their clinical and commercial distribution strategies for cell and gene therapies.
Download our White Paper to learn about the new requirements addressed in ISO 21973 and how to ensure your compliance at every step of the journey.
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC